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Spinal Cord Stimulators:
an Introduction
Steven Falowski, MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania

Background
Pain can be divided into two broad categories, nociceptive pain and neuropathic pain. Nociceptive
pain is a dull, throbbing pain which results from irritated nerves after physical tissue injury. This is
seen commonly in cancer or after a fracture. Nociceptive pain is amenable to treatment with pain
medications such as opioids and/or anti-inflammatories. Neuropathic pain is described as burning,
shooting, or shocking pain. This type of pain results from nerve damage or abnormal nerve conduction such as pain exhibited with failed back syndrome, post surgical pain, neuromas, shingles, and
complex regional pain syndrome (previously called RSD or causalgia). Neuropathic pain tends to
be resistant to treatment with pain medications. Neurostimulation has been an effective treatment
option for the management of chronic neuropathic pain. It is a reversible therapy which can even be
tested before permanent implantation.
Spinal cord stimulation (SCS) is an adjustable, non-destructive, neuromodulatory procedure which
delivers therapeutic doses of electrical current to the spinal cord or to a targeted nerve. This lowvoltage stimulation can block the transmission of pain. The enthusiasm for SCS began with the
introduction of the gate control theory for pain control by Melzack and Wall in 1965 1.They noted
that stimulation of large myelinated fibers of peripheral nerves resulted in paresthesias and blocked
the activity in small nociceptive projections. In other words, pain receptors compete with each other
and with other sensory afferents. Appropriate stimulation of a “rival” afferent can effectively block a
pain signal. This is why rubbing your chin after its been hit relieves the pain – the bump is still present,
but the rubbing blocks it. The SCS system is implanted in a space surrounding the spinal cord, called
the epidural space, where it stimulates the dorsal columns which can mask the sensation of pain by
producing a tingling sensation.

Figure 1
A patient that had persistent
neuropathic pain in his back and his
legs despite anterior and posterior spinal
reconstructive surgery.

Patient Selection
Some of the criteria listed below can be used to determine candidates for neurostimulation:
• Conservative therapies have failed to adequately help the pain.
• Further traditional surgical intervention is not indicated.
• No serious untreated drug habituation for the pain condition exists.
• Psychological evaluation and clearance for implantation have been received, sorting out
untreated depression or anxiety, addiction, or other behavioral disorders.
• No medical issues exist that would present problems with doing the surgery.

Indications
The most common indications include post-laminectomy syndrome or failed back surgery syndrome
(FBSS), complex regional pain syndrome (CRPS) or reflex sympathetic dystrophy (RSD), ischemic
limb pain, and angina. Scattered reports regarding the treatment of intractable pain due to other
causes including visceral/abdominal pain, cervical neuritis pain, spinal cord injury pain, post-herpetic
neuralgia, and neurogenic thoracic outlet syndrome have also appeared in the literature.

Surgical Technique
The procedures are most commonly performed by neurosurgeons or anesthesiologists specializing
in pain management 2-5. A lead is temporarily utilized to cover a wide area for pain control. The
lead, or electrode, is implanted into the epidural space. The lead is attached to a power source called
the pulse generator (or commonly known as the battery). This is then connected to an outside or
external system which is held in place by sterile dressings. The unit is then tested for efficacy during
a screening period, which is usually 3-10 days.
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Figure 2
The patient received an implanted
transverse tripole electrode in the thoracic
spine. The new electrode has the ability
of focusing the electrical field into the
dorsal column to maximize the paresthesia
into the back while avoiding painful
stimulation of the nerves into the ribs.
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If relief is obtained at this point, the system may
be implanted permanently. The stimulator is
usually placed in an area where the skin will
not be irritated and the unit will not be pressing against bone. The abdomen and buttocks
are common locations.

Benefits
Neurostimulation has been shown to have a
50% improvement in pain relief, reduce the use
of medications, and allow the person experience
an improvement in their quality of life 6-7. These
benefits are expected to increase with improvements in the technology and in understanding
of how pain signals are generated and gated in
the nervous system. It is important to realize
that neurostimulation is a treatment option
along the continuum of pain control.

Potential Adverse Effects
Surgical risks associated with an implant include
hematoma, infection, and possible leakage of
cerebrospinal fluid. Because this is a device,
there can be malfunction of the hardware or can
have disruption in the settings by other signals;
for example, patients with an SCS are advised
to turn it off before going through an anti-theft
device in a retail store; additionally, patients
with an SCS can not undergo a magnetic resonance imaging (MRI) scan.
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Summary
Spinal cord stimulation therapy has been available and approved for over two decades. In
the last five years, there have been significant
advances in the technology: smaller, rechargeable batteries; better electrodes; and improved
implantation techniques. More physicians are
adapting this therapy in their practice for pain
management and we are effectively improving
patients’ lives.
The treatment of chronic pain remains challenging. Experience in the technique and the
equipment has made SCS a much more reliable and safe modality. Like all the modalities
performed for chronic pain management,
its results are favorable. It is important to
remember that the goal of neurostimulation is
to reduce pain, rather than to eliminate pain.
Very few other invasive modalities can claim
this success rate with a few years of follow-up.
Spinal cord stimulation has earned a well established and firm role in contemporary chronic
pain management.
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Further information is available at the Neural
Interfaces Program Website of the NIH, http://
www.ninds.nih.gov/funding/research/npp/
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